← Map · Health Care Equipment · S&P 500
BAX BAXTER INTERNATIONAL $12.0B
No on this lens. Connected care is the device line. AI is still exploration.
4 of 15
Reach, Weight, and Proof.
What they are doing
Baxter's growth story in the latest quarter is connected devices: patient support, Connex 360 monitoring, and the Dynamo stretcher. The annual report treats artificial intelligence separately, as a thoughtful exploration inside operational excellence, plus a risk factor. That is not a named product in the offer.
Why the score
- Reach 1 not 2: one line about exploring AI for how they run the company. Not a second function.
- Weight 1 not 2: exploration, not a live hygiene tool they have named in production.
- Proof 2 not 1: the annual report names the exploration and ties it to operations.
- Proof 2 not 3: nothing you can see running as an AI product.
What would move it next quarter: A named AI feature on a bed, pump, or monitor, with a use you can point to. Another connected-care sales line will not move this.
Open these first
Evidence
Operational excellence includes increased automation and digitization, including thoughtful exploration of artificial intelligence initiatives. A separate risk says incorporating AI into products and operations could affect the business. Exploration, not a launched product.
Healthcare Systems and Technologies sales were about 801 million dollars, up 4 percent, on patient support systems and front line care. The release does not name an AI product.